Leukemia articles & resources on Made-in-China.com

China Donates First Stem Cells to Malaysia

Dec 18, 2015

A Chinese man has donated hemopoietic stem cells (HSCs) to a patient with blood disease in Malaysia. Lu, 22, from south China's Guangxi Zhuang Autonomous Region, signed up to be a stem cell donor with the China Marrow Donor Program (CMDP) ...

Tags: Stem Cells, donor

Group Are Trying to Pressure Apple Into Abandoning Hazardous Chemicals Used to Make iPhone

Mar 13, 2014

An environmental protection group and labor rights group are trying to pressure Apple into abandoning two hazardous chemicals used to make iPhones. Green America and China Labor Watch launched their campaign Wednesday to protect the ...

Tags: Consumer Electronics, iPhone

Babies Who Develop Leukemia Appear to Inherit an Unfortunate Combination

Feb 27, 2014

Babies who develop leukemia during the first year of life appear to inherit an unfortunate combination of genetic variations that can make the infants highly susceptible to the disease, according to a new study at Washington University ...

Tags: Leukemia, Genetic Predisposition, DNA, gene

A Group of Researchers Are Responsible for Tumor Progression

Feb 26, 2014

A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Universit- de Montr-al discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. That ...

Tags: Immunology and Cancer(IRIC), Leukemia Treatment, Brg1 gene

ASX:CGS's Technology Will Be Used in a Large Paediatric Clinical Trial in The US

Feb 12, 2014

Medical technology company Cogstate Limited (ASX:CGS) has today announced its technology will be used in a large paediatric clinical trial in the United States. Under the contract worth approximately US$1.4 million over four years, the ...

Tags: Health, Medicine

Miltenyi Biotec Receives Approval From FDA for Clinimacs CD34 Reagent System

Feb 10, 2014

German biotechnology company Miltenyi Biotec has received the US Food and Drug Administration's(FDA)approval for its CliniMACS CD34 reagent system to prevent graft-versus-host disease(GVHD)in the treatment of acute myeloid leukemia(AML). ...

Tags: Miltenyi Biotec, Blood, Medicine

Health Care Reform Survives a Lawsuit

Jan 21, 2014

The New York Times: Health Care Reform Survives A Lawsuit A long-shot lawsuit that could have damaged the effectiveness of health care reform got a well-deserved brushoff from a federal district judge on Wednesday. The suit was brought ...

Tags: New York Times, Alemtuzumab, Maternity Leave, FDA

IBM Faces a Puzzle That Might Give Even The World's Greatest Detective Pause

Jan 13, 2014

IBM faces a puzzle that might give even the world's greatest detective pause: How to grow its "Jeopardy"-conquering Watson supercomputer into a $10-billion business within a decade. The company hopes to boost Watson's profit-making ...

Tags: IBM, Watson, supercomputer, investment

IBM Is Spending $1 Billion to Give Watson Its Own New York City-Based Business Division

Jan 10, 2014

IBM is spending $1 billion to give Watson its own New York City–based business division as it seeks commercial applications for its Jeopardy-winning supercomputer in healthcare and other fields. But will medical companies truly find a ...

Tags: IBM, Computer Products

A New Combination of Drugs Might Prolong Life in Certain Older Leukemia Patients

Jan 10, 2014

A new combination of drugs might prolong life in certain older leukemia patients, a new study suggests. The research, led by German scientists, included nearly 800 older people (average age 73) who had been diagnosed with chronic ...

Tags: Drug, Drug Combo, Leukemia

The FDA Has Rejected The New Multiple Sclerosis Drug Lemtrada

Jan 6, 2014

The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some serious risks. The agency asked the maker, Genzyme, to test the drug in more clinical trials. The drug was ...

Tags: FDA, Lemtrada, Genzyme, relapsing-remitting MS, rejection

The First Detailed Molecular Structure of a Member of The Tet Family of Enzymes

Dec 30, 2013

Scientists have obtained the first detailed molecular structure of a member of the Tet family of enzymes. The finding is important for the field of epigenetics because Tet enzymes chemically modify DNA, changing signposts that tell the ...

Tags: enzymes, epigenetics, Tet enzymes

Women with Aggressive Breast Cancer Have a Slightly Improved Chance of Staying Cancer-Free

Dec 27, 2013

Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say. However, the improvement was not statistically ...

Tags: aggressive breast cancer, targeted therapy with chemotherapy

Adding Cancer Drug Dasatinib to Therapy May Slow Progression of Advanced Breast Cancer

Dec 26, 2013

Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests. The drug, sold under the name Sprycel, is already approved in the United States for chronic ...

Tags: cancer drug, dasatinib, hormone therapy, advanced breast cancer

Gene Therapy Might Be a Powerful Weapon Against Leukemia and Other Blood Cancers

Dec 26, 2013

Preliminary research shows that gene therapy might one day be a powerful weapon against leukemia and other blood cancers. The experimental treatment coaxed certain blood cells into targeting and destroying cancer cells, according to ...

Tags: gene therapy, leukemia, blood cancer

Leukemia

Related Products